US FDA opens office in Delhi, around 100 approved plants to come under vigilance

Around 100 US FDA approved pharma plants in different parts of the country will come under the direct radar of the US regulatory authorities, as the US FDA has opened its first office in the country in New Delhi on January 15. By establishing its offices in India, the US FDA aims for better coordination with the regulatory authorities and the industry in India to ensure safety of food and medicinal products being exported to the US from India.

The details can be read here.